+ Bookmark This Page    
Preferences  |  11:39 PM
  1. Home
  2. Latest Press Releases
  3. Submit Press Releases
  1. PR Home
  2. News Archive
  3. By Category
  4. By Location
  5. By Date
  6. By Tag
  7. Newsletter
  8. 40,000 RSS Feeds
  9. Submit Free Press Release
   
Filter News
Show All Results

Show Filtered Results

Category
- Government (x)

Country
- New Zealand (x)

State / Province
(To see all states,
remove category filter)


City / Town
Select State First

Newly Revised Guidelines for Managing Thyroid Cancer Published in Thyroid Journal

The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer.
 

FOR IMMEDIATE RELEASE

PR Log (Press Release)Nov 05, 2009 – Contact: Julia Chapman, Mary Ann Liebert, Inc., (914) 740-2100, ext. 2147, jchapman@liebertpub.com

Newly Revised Guidelines for Managing Thyroid Cancer Published in Thyroid Journal

New Rochelle, NY—The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. (http://www.liebertpub.com). Thyroid is the official journal of the American Thyroid Association (ATA). The ATA’s revised Management Guidelines and accompanying editorials are available free online at http://www.liebertpub.com/thy

The ATA Guidelines Taskforce updated and revised the initial management guidelines it released in 2006 because of the large number of new clinical research findings that have been published in the last three years. Thyroid nodules continue to be a common clinical problem, and the prevalence of differentiated thyroid cancer is rapidly increasing.

For managing thyroid nodules, the guidelines focus on the initial presentation, clinical and ultrasound evaluation, the decision to perform fine-needle biopsy and how to interpret the results, and the management of benign thyroid nodules.

The revised guidelines for managing thyroid cancer provide recommendations for optimal surgical management, the use of radioiodine remnant ablation, thyroid hormone suppression therapy, as well as long-term surveillance based on ultrasound, other imaging modalities, and laboratory testing.

Accompanying the Management Guidelines published in Thyroid are four editorials that include commentary on the preparation of the revised guidelines, highlights of the 2009 revisions, the transition from consensus- to evidence-based best practices, and a surgical perspective. The editorials were written by Charles H. Emerson, MD, Editor-in-Chief of Thyroid and Professor Emeritus of Medicine at the University of Massachusetts School of Medicine, in Worcester; Leonard Wartofsky, MD, from Washington Hospital Center (District of Columbia); jointly by Efisio Puxeddu, MD, PhD, from University of Perugia, and Sebastiano Filetti, MD, from University of Rome, Italy; and jointly by Dana Hartl, MD, PhD, and Jean-Paul Travagli, MD, from Institut Gustave Roussy, Villejuif, France.

“The Taskforce worked very hard to draft guidelines that were clinically relevant and evidence-based. We hope that they will provide a framework for the care of patients with nodular thyroid disease and thyroid cancer that will be accepted throughout the world,” said David S. Cooper, MD, ATA Guidelines Taskforce Chair and Professor of Medicine at Johns Hopkins University (Baltimore, MD).

“The newly revised ATA Task Force Guidelines are a worthy successor to the original guidelines published in 2006. They will be carefully scrutinized by clinical investigators and used on a daily basis by physicians as they evaluate thyroid nodules and manage thyroid cancer," said Charles H. Emerson, MD.

“Guidelines should be designed to guide, and this revision signals the maturation of internationally well received advice on the management of patients with potentially serious disease. Nobody should underestimate the danger of badly managed thyroid cancer and this American Thyroid Association Task Force has produced a first class guide for practitioners,” said Terry Davies, MD, President of the American Thyroid Association and Florence and Theodore Baumritter Professor of Medicine, Mount Sinai School of Medicine (New York, NY).

Thyroid is an authoritative peer-reviewed journal published monthly in print and online. The Journal publishes original papers and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. A complete table of contents and free sample issue may be viewed online at http://www.liebertpub.com/thy
   
Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Diabetes Technology & Therapeutics and Journal of Women’s Health. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 60 journals, books, and newsmagazines is available at www.liebertpub.com

Mary Ann Liebert, Inc.    140 Huguenot St., New Rochelle, NY 10801-5215    www.liebertpub.com
                Phone: (914) 740-2100    (800) M-LIEBERT    Fax:  (914) 740-2101

# # #

Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Diabetes Technology & Therapeutics and Journal of Women’s Health. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 60 journals, books, and newsmagazines is available at www.liebertpub.com


To embed this press release, copy and paste the following HTML code into your webpage-
# # # Click to see PDF Version of this Press Release

Email to a Friend     Visit Press Room       Previous News   Next News


Email Contact:Click to email (Partial email =  @liebertpub.com) Email Verified
Issued By:Mary Ann Liebert, Inc., publishers
Address:140 Huguenot St, 3rd Floor
City/Town:New Rochelle
State/Province:New York
Zip:10801
Country:United States
Categories:Health, Medical, Science
Last Updated:Nov 05, 2009
Shortcut:http://prlog.org/10402436

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases.   Report Abuse


Latest Press Releases From “Mary Ann Liebert, Inc., publishers”


Upcoming Press Releases...


Most Viewed Weekly

Hemispherx BioPharma, Inc hit by shareholder lawsuit - 3050 views

STEC, Inc. hit by shareholder lawsuit - 1530 views

Youbet.com, Inc. board under investigation - 1376 views

25 Smokin’ Figurados Interviewed on DogWatch Cigar Radio - 1265 views

The Boeing Company hit by shareholder lawsuit - 1053 views


Daily News!

Global Server Virtualization Software Market

Six CFOs Walk Away with Accolades at this year’s MENA CFO Awards

DeLime Imaging Product Photography Adds Capability to Photograph Larger 360 Degree Rotating Objects

Special Black Friday and Cyber Monday Deals to be Offered at Bath Products store, eBubbles.com

REACH Personal Branding announces partnership with videoBIO, leader in web-based video biographies

Previous   Next

Nov 05, 2009 News

Nov 2009 News

Are you a Journalist?

For Businesses ...

Tutorial on Free Marketing


November 2009
Mo Su Sa Fr Th We Tu
23 22 21 20 19 18 17
16 15 14 13 12 11 10
9 8 7 6 5 4 3
2 1
October 2009
31 30 29 28 27



  1. SiteMap
  2. Contact PR Log
  3. Privacy Policy
  4. Terms of Use
  5. Copyright Notice